Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,494 | -5,682 | -3,944 | -1,744 | 405 |
| Depreciation Amortization | 89 | 393 | 302 | 206 | 107 |
| Accounts receivable | N/A | 102 | 102 | 101 | 60 |
| Accounts payable and accrued liabilities | 413 | -74 | 50 | 505 | 132 |
| Other Working Capital | 378 | 268 | 355 | 470 | 620 |
| Other Operating Activity | -351 | 483 | 247 | -327 | -26 |
| Operating Cash Flow | $-965 | $-4,510 | $-2,888 | $-789 | $1,298 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 103 | 103 | 103 | 103 |
| Other Investing Activity | 0 | 206 | 206 | 206 | 206 |
| Investing Cash Flow | $N/A | $309 | $309 | $309 | $309 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -2,760 | N/A | N/A | N/A |
| Debt Repayment | -483 | N/A | -1,815 | -1,122 | -445 |
| Common Stock Issued | N/A | 4,000 | 4,000 | N/A | N/A |
| Other Financing Activity | 2 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-481 | $1,240 | $2,185 | $-1,122 | $-445 |
| Beginning Cash Position | 2,220 | 5,181 | 5,181 | 5,181 | 5,181 |
| End Cash Position | 774 | 2,220 | 4,787 | 3,579 | 6,343 |
| Net Cash Flow | $-1,446 | $-2,961 | $-394 | $-1,602 | $1,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -965 | -4,510 | -2,888 | -789 | 1,298 |
| Free Cash Flow | -965 | -4,510 | -2,888 | -789 | 1,298 |